Enhancing Anti-Cancer Immunotherapy by Disruption of the non-Receptor Tyrosine Kinase Fes
Enhancing Anti-Cancer Immunotherapy by Disruption of the non-Receptor Tyrosine Kinase Fes
通过破坏非受体酪氨酸激酶 Fes 增强抗癌免疫治疗
批准号：
476093
负责人：
Laight Brian
金额：
$7.65万
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-11-01 至 2025-11-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer is the leading cause of death in Canada, causing one-third of all deaths. Cancer is normally treated with chemotherapy, radiation, or surgery. However, these treatments are unsafe and often ineffective, causing a variety of other long-term health p
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immune Modulation by Bioengineered Oncolytic Viruses Promotes Robust Anti-Tumour Immunity
-
批准号：428907
-
项目类别：Studentship Programs
-
资助金额：$1.27万
-
财政年份：2019
-
负责人：Laight Brian
-
依托单位：
海外基金
